Kristen Pettit

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster et al. · Blood · 2020 · 322 citations · Full text

Medicine, Hematology, Oncology +13

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Jason Gotlib, Andreas Reiter, Deepti Radia et al. · Nature Medicine · 2021 · 147 citations · Full text

Medicine, Oncology, Pharmacology +12

Update on a Phase 1/2 First-in-Human Study of the Menin-KMT2A (MLL) Inhibitor Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Harry P. Erba, Amir T. Fathi, Ghayas C. Issa et al. · Blood · 2022 · 71 citations

Medicine, Pharmacology, Pharmacotherapy +13

A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia

Amy Wang, Howard Weiner, Margaret Green et al. · Journal of Hematology & Oncology · 2018 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Preliminary Data on a Phase 1/2A First in Human Study of the Menin-KMT2A (MLL) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Eunice S. Wang, Jessica K. Altman, Kristen Pettit et al. · Blood · 2020 · 65 citations

Medicine, Hematology, Pharmacology +11